PREVEN EMERGENCY CONTRACEPTIVE KIT (ethinyl estradiol; levonorgestrel) by Teva. Approved for pregnancy. First approved in 1998.
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
PREVEN is an oral emergency contraceptive kit containing ethinyl estradiol and levonorgestrel, designed to prevent pregnancy when taken shortly after unprotected intercourse. It works by inhibiting or delaying ovulation and altering cervical mucus to impede sperm transport. This product addresses an urgent clinical need in reproductive health with time-sensitive dosing requirements.
This product is approaching loss of exclusivity with moderate competitive pressure (30), signaling a contracting brand team and shift toward generic/OTC transition management roles.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
PREVEN offers limited career growth opportunities given its LOE-approaching status and zero linked jobs in current data; professionals on this product should expect transition planning toward new launches or portfolio roles. Working on PREVEN is best suited for those seeking stability in a mature therapeutic area or those building expertise before moving to growth-stage franchises.
Worked on PREVEN EMERGENCY CONTRACEPTIVE KIT at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.